SAN DIEGO, Nov. 12, 2013 /PRNewswire/ -- Orexigen(R) Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, today announced business and financial results for the third quarter ended September 30, 2013.
Help employers find you! Check out all the jobs and post your resume.
